相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanisms of boundary formation by Eph receptor and ephrin signaling
Jordi Cayuso et al.
DEVELOPMENTAL BIOLOGY (2015)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
The paradigm of mutant p53-expressing cancer stem cells and drug resistance
Yoav Shetzer et al.
CARCINOGENESIS (2014)
Engineered reversal of drug resistance in cancer cells-metastases suppressor factors as change agents
Vinod Kumar Yadav et al.
NUCLEIC ACIDS RESEARCH (2014)
The role of EPH receptors in cancer-related epithelial-mesenchymal transition
Rui-Xin Li et al.
CHINESE JOURNAL OF CANCER (2014)
3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing
Paola Longati et al.
BMC CANCER (2013)
Ephrin-B2 controls PDGFRβ internalization and signaling
Akiko Nakayama et al.
GENES & DEVELOPMENT (2013)
Inhibition of Ephrin B3-mediated survival signaling contributes to increased cell death response of non-small cell lung carcinoma cells after combined treatment with ionizing radiation and PKC 412
S. Stahl et al.
CELL DEATH & DISEASE (2013)
BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II
Jai-Hyun Kim et al.
ANGIOGENESIS (2012)
Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells
Weijia Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth
Maria Angeles Abengozar et al.
BLOOD (2012)
Mutant p53 cooperates with ETS2 to promote etoposide resistance
Phi M. Do et al.
GENES & DEVELOPMENT (2012)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon Cancer
Ming Ming Zhu et al.
PLOS ONE (2012)
Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop
Fabio Valenti et al.
CELL CYCLE (2011)
Peptide-Protein Interactions Suggest That Acetylation of Lysines 381 and 382 of p53 Is Important for Positive Coactivator 4-p53 Interaction
Subrata Debnath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration
Aycan Sentuerk et al.
NATURE (2011)
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2011)
EphrinB2 induces pelvic-urethra reflex potentiation via Src kinase-dependent tyrosine phosphorylation of NR2B
Hsi-Chin Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Suphansa Sawamiphak et al.
NATURE (2010)
KEGG for representation and analysis of molecular networks involving diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2010)
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Elena B. Pasquale
NATURE REVIEWS CANCER (2010)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
iRefIndex: A consolidated protein interaction database with provenance
Sabry Razick et al.
BMC BIOINFORMATICS (2008)
Neuropilin-1 Upholds Dedifferentiation and Propagation Phenotypes of Renal Cell Carcinoma Cells by Activating Akt and Sonic Hedgehog Axes
Ying Cao et al.
CANCER RESEARCH (2008)
EphrinB1 signals from the cell surface to the nucleus by recruitment of STAT3
Yong-Sik Bong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
Why do hubs tend to be essential in protein networks?
Xionglei He et al.
PLOS GENETICS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition
E Avizienyte et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
EPH receptor signalling casts a wide net on cell behaviour
EB Pasquale
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Peeling the yeast protein network
S Wuchty et al.
PROTEOMICS (2005)
Evidence for dynamically organized modularity in the yeast protein-protein interaction network
JDJ Han et al.
NATURE (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cancer chemoresistance: the relationship between p53 and multidrug transporters
JA Bush et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Coexpression of ephrin-Bs and their receptors in colon carcinoma
WB Liu et al.
CANCER (2002)
Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1
J Sampath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Lethality and centrality in protein networks
H Jeong et al.
NATURE (2001)
Error and attack tolerance of complex networks
R Albert et al.
NATURE (2000)
分享论文
